Back
MoonLake Immunotherapeutics Stock Predictions
Sponsored
MLTX
Sponsored
Election Shock on August 19th?
Click here now to see the evidence I've gathered.
Buy
54
MLTX
MoonLake Immunotherapeutics
Last Price:
45.19
Seasonality Move:
62.44%
7 Day Trial
ALL ACCESS PASS
$
7
$50 trade to make today with huge potential!
Click here to access my #1 options strategy for overnight wins starting with $50!MoonLake Immunotherapeutics Stock Forecast
- Over the next 52 weeks, MoonLake Immunotherapeutics has on average historically risen by 100.3% based on the past 3 years of stock performance.
- MoonLake Immunotherapeutics has risen higher in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
-
Is MoonLake Immunotherapeutics Stock Undervalued?
The current MoonLake Immunotherapeutics [MLTX] share price is $42.43. The Score for MLTX is 54, which is 8% above its historic median score of 50, and infers lower risk than normal. - MLTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will MoonLake Immunotherapeutics Stock Go Up Next Year?
- Over the next 52 weeks, MoonLake Immunotherapeutics has on average historically risen by 100.3% based on the past 3 years of stock performance.
MoonLake Immunotherapeutics Stock Rating
Buy
54
MoonLake Immunotherapeutics (MLTX)
is a Buy
Is MoonLake Immunotherapeutics overpriced?
- MoonLake Immunotherapeutics has risen higher in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
MoonLake Immunotherapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Switzerland
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
moonlaketx.com
52-Week Data
52-Week High:
64.98
52-Week Low:
22.12
Prediction Charts
Market Cap:
2.67B
Price in USD:
42.43
Volume:
337.78K
Beta:
1.30
Technical Analysis
SMA50:
46.86
SMA100:
52.50
SMA200:
52.61
52-Wk Change:
101.47%
Stock Predictions
-
Is MoonLake Immunotherapeutics stock public?
Yes, MoonLake Immunotherapeutics is a publicly traded company. -
What is the MoonLake Immunotherapeutics stock quote today?
The MoonLake Immunotherapeutics stock price is 42.43 USD today. -
How to buy MoonLake Immunotherapeutics stock online?
You can buy MoonLake Immunotherapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Apr-15 | 43.79 | 43.61 | 44.17 | 42.64 |
Apr-16 | 43.14 | 43.50 | 43.87 | 43.14 |
Apr-17 | 43.71 | 43.53 | 43.88 | 43.45 |
Apr-18 | 43.59 | 42.28 | 43.70 | 42.16 |
Apr-19 | 42.27 | 42.15 | 42.80 | 40.68 |
Apr-22 | 42.41 | 41.02 | 42.51 | 40.72 |
Apr-23 | 41.48 | 43.25 | 43.26 | 41.45 |
Apr-24 | 43.60 | 42.43 | 43.60 | 41.80 |
Apr-25 | 41.68 | 42.25 | 42.66 | 41.20 |
Apr-26 | 42.37 | 42.49 | 43.05 | 42.16 |
Apr-29 | 42.82 | 41.77 | 43.17 | 40.97 |
Apr-30 | 41.25 | 40.93 | 41.76 | 40.45 |
May-1 | 41.11 | 42.82 | 43.65 | 41.11 |
May-2 | 43.19 | 42.43 | 43.70 | 42.40 |
MoonLake Immunotherapeutics Earnings
MoonLake Immunotherapeutics Earnings Report: Per Share MoonLake Immunotherapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
MoonLake Immunotherapeutics Forecast Revenue Growth
MoonLake Immunotherapeutics Stock Analysis: Historical quarterly revenues per share for MoonLake Immunotherapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.37 per share, a decrease this year of $0.29 per share, and a decrease next year of $0.59 per share.
* MoonLake Immunotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.